(IBRX)

ImmunityBio Inc (IBRX) EPS is poised to hit -0.11 next quarter: How Investors Can Make It Count the Most?

Steve Mayer

ImmunityBio Inc (NASDAQ: IBRX) started the day on Wednesday, with a price increase of 2.80% at $2.2, before settling in ...

-20.62% percent quarterly performance for ImmunityBio Inc (IBRX) is not indicative of the underlying story

Steve Mayer

ImmunityBio Inc (NASDAQ: IBRX) on Monday, plunged -4.67% from the previous trading day, before settling in for the closing price ...

ImmunityBio Inc (IBRX) plunged -0.48 in the last month: It’s impossible to believe the numbers

Zack King

On Friday, ImmunityBio Inc (NASDAQ: IBRX) was -0.48% drop from the session before settling in for the closing price of ...

ImmunityBio Inc (IBRX)’s latest performance is not what we had anticipated

Zack King

On Friday, ImmunityBio Inc (NASDAQ: IBRX) was 7.76% up from the session before settling in for the closing price of ...

ImmunityBio Inc (IBRX) EPS growth this year is 27.10%: Get Prepared for Trading Lift Off

Shaun Noe

ImmunityBio Inc (NASDAQ: IBRX) established initial surge of 3.60% at $2.3, as the Stock market unbolted on Wednesday, before settling ...

ImmunityBio Inc (IBRX) is ready for next Episode as it posted an annual sales of 14,750 K

Zack King

ImmunityBio Inc (NASDAQ: IBRX) on Tuesday, plunged -7.96% from the previous trading day, before settling in for the closing price ...

ImmunityBio Inc (IBRX)’s latest performance is not what we had anticipated

Zack King

ImmunityBio Inc (NASDAQ: IBRX) kicked off on Friday, down -5.14% from the previous trading day, before settling in for the ...

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.